Broughton Group, a leading contract research organisation with over 15 years of expertise in testing and regulation, has joined the Cannabis Industry Council (CIC), reinforcing its commitment to advancing industry standards and supporting the growth of the UK’s medical cannabis, hemp, and CBD sectors.
The CIC serves as a pivotal membership organisation representing the entire UK cannabis industry, encompassing over 100 members across the cannabis supply chain. It unites organisations, businesses, and advocacy groups dedicated to shaping the future of cannabis in the UK. The council focuses on credibility, patient access, and industry influence, bringing together key stakeholders to drive meaningful change.
As a member, Broughton will contribute its expertise in regulatory compliance, data-driven insights, and product safety to support the council’s initiatives. Chris Allen, CEO of Broughton, remarked, “Joining the Cannabis Industry Council is a natural step for Broughton as we continue to support the development of safe, effective, and high-quality cannabis products. We are excited to collaborate with other members, share our knowledge, and work together to shape the future of the industry.”
The CIC is committed to advancing the industry by driving progress in key areas. A primary focus is advocating for policy reforms with government bodies and regulators to ensure legislation supports sustainable growth. Additionally, the CIC works to elevate the cannabis sector’s profile, expand access to medical cannabis, and foster the growth of the CBD and hemp markets.
Mike Morgan-Giles, CEO of the CIC, added, “The medical cannabis sector faces a range of regulatory and policy challenges, and we look forward to Broughton contributing to developing solutions in the interests of the sector.”
Both Broughton and the CIC are committed to upholding rigorous standards for cannabis products, ensuring the industry’s credibility and integrity. Broughton’s expertise in regulatory compliance and product testing aligns perfectly with these goals. The company’s work ensures that product developers maintain consistency and adhere to stringent safety and quality requirements, a crucial factor in gaining consumer and regulatory trust.
As a Schedule 1 licensed entity, Broughton is positioned to provide specialised guidance across critical areas such as regulatory pathways, stability testing, and toxicological assessments. The company’s expertise ensures that cannabis-based products meet the highest standards, contributing to the safe and responsible development of the industry.
A scientific approach is crucial in supporting the CIC’s mission of fostering evidence-based decision-making. With a focus on quality and safety, Broughton’s role in the sector combines compliance with pushing the boundaries of what is possible within cannabis research and product development.
By working alongside other industry leaders within the council, Broughton will play an active role in shaping policies, ensuring that cannabis-based products meet the necessary standards for safety, efficacy, and compliance.
Broughton’s membership in the CIC represents a significant step towards fostering collaboration among scientific experts, policymakers, and businesses. This partnership is an opportunity for the company to help set industry standards and drive innovation.
With a strong commitment to advancing scientific knowledge, Broughton supports companies in navigating the complexities of cannabis laws, regulations, and emerging market trends. Its dedication to innovation and research ensures that cannabis-based products are not only fully compliant but are also developed with cutting-edge scientific insights and best practices.
For businesses navigating regulatory hurdles, Broughton’s specialised services can help meet the highest industry standards.
